Hemolytic-uremic syndrome caused by gemcitabine

This publication has 4 references indexed in Scilit:

• Gemcitabine-Induced Hemolytic Uremic Syndrome: a Case Report
  JNCI Journal of the National Cancer Institute, 1997
• Feasibility of sequential high-dose chemotherapy and peripheral blood stem cell support for pediatric central nervous system malignancies
  Medical and Pediatric Oncology, 1997
• Phase II trial of gemcitabine (2,2′-difiuorodeoxycytidine) in patients with adenocarcinoma of the pancreas
  Investigational New Drugs, 1994
• Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registry.
  Journal of Clinical Oncology, 1989